Treatment considerations for bluetongue virus serotype-3 cases in sheep

  • Fiona Lovatt
  • , Rachael Tarlinton
  • , Margit Groenevelt

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: Bluetongue virus (BTV) serotype-3 (BTV-3) has been circulating in the Netherlands since September 2023 and was first reported in Kent in the UK in November 2023, picked up via the annual bluetongue surveillance programme. It is a highly pathogenic strain in sheep with limited preventive measures once virus is circulating in the biting midge population. At the time of publication there is no BTV-3 vaccine available and no cross-protection from other BTV vaccine strains. There are no specific antiviral medicines available, and therapy focuses on nursing care and anti-inflammatory medicines to reduce clinical signs, although early euthanasia decisions need to be considered on the grounds of animal welfare. Aim of the article: This article takes the experiences of vets from the Netherlands and describes what practitioners might be able to do to treat clinical cases of BTV-3, with thanks to Schapendokter (2023) for sharing their practice protocols.

Original languageEnglish
Pages (from-to)198-203
Number of pages6
JournalIn Practice
Volume46
Issue number4
DOIs
Publication statusPublished - 3 May 2024

Bibliographical note

Publisher Copyright:
© 2024 British Veterinary Association.

Fingerprint

Dive into the research topics of 'Treatment considerations for bluetongue virus serotype-3 cases in sheep'. Together they form a unique fingerprint.

Cite this